Chandler D. Robinson

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

MNPR

Current role

CEO, Board Member

2014-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Monopar Therapeutics (MNPR)	Chief Executive Officer and Director	$700,000	$550,000	$6,263,958	$2,703,862	$420,000	—	$10,637,821
2024	Monopar Therapeutics (MNPR)	Chief Executive Officer and Director	$603,200	$300,000	—	—	$241,280	—	$1,144,480
2023	Monopar Therapeutics (MNPR)	Chief Executive Officer and Director	$580,000	—	$534,087	$534,080	$130,500	—	$1,778,667
2022	Monopar Therapeutics (MNPR)	Chief Executive Officer and Director	$550,000	—	$446,662	$446,662	$158,125	—	$1,601,448
2020	Monopar Therapeutics (MNPR)	MD, Chief Executive Officer and Director	$504,488	—	$347,752	$637,924	$98,400	—	$1,588,564
2019	Monopar Therapeutics (MNPR)	MD, Chief Executive Officer and Director	$386,250	$62,494	—	—	$37,506	$55,000	$541,250

No earnings-call appearances or filed executive changes recorded yet.